VIT 100

Drug Profile

VIT 100

Alternative Names: ChelASE; ProliferASE

Latest Information Update: 22 Jul 2010

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Immusol
  • Developer iTherX Pharmaceuticals
  • Class Antipsoriatics; Eye disorder therapies; Skin disorder therapies
  • Mechanism of Action Protein synthesis inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • No development reported Glaucoma; Hypertrophic scars; Keloids; Proliferative vitreoretinopathy; Psoriasis

Most Recent Events

  • 24 Aug 2007 This programme is still in active development
  • 15 Apr 2003 Phase-I clinical trials in Hypertrophic scars in USA (Topical)
  • 15 Apr 2003 Phase-I clinical trials in Keloids in USA (Topical)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top